clovir permeates the cornea primarily by passive diffusion. Nucleoside and nucleobase transporters on rabbit cornea and corneal epithelial cell line, SIRC, are functionally different, undermining the utility of the SIRC cell line as an in vitro screening tool for elucidating the corneal permeation mechanism of nucleoside analogs. Uptake and transport studies were performed for 2 minutes and 120 minutes, respectively, at 34°C. Thymidine uptake by SIRC displayed saturable kinetics (K m = 595.9 ± 80.4μM, and V max = 289.5 ± 17.2 pmol/min/mg protein). Uptake was inhibited by both purine and pyrimidine nucleosides but not by nucleobases. [ 3 H]thymidine uptake was sodium and energy independent but was inhibited by nitrobenzylthioinosine at nanomolar concentrations. Adenine uptake by SIRC consisted of a saturable component (K m = 14.4 ± 2.3μM, V max = 0.4 ± 0.04 nmol/min/mg protein) and a nonsaturable component. Uptake of adenine was inhibited by purine nucleobases but not by the nucleosides or pyrimidine nucleobases and was independent of sodium, energy, and nitrobenzylthioinosine. [ 3 H]ganciclovir uptake involved a carrier-mediated component and was inhibited by the purine nucleobases but not by the nucleosides or pyrimidine nucleobases. However, transport of [ 3 H]adenine across the isolated rabbit cornea was not inhibited by unlabeled adenine. Further, corneal permeability of ganciclovir across a 100-fold concentration range remained constant, indicating that ganci-
The purpose of this study was to investigate the expression of nucleoside/nucleobase transporters on the Statens Seruminstitut rabbit corneal (SIRC) epithelial cell line and to evaluate SIRC as an in vitro screening tool for delineating the mechanism of corneal permeation of nucleoside analogs. SIRC cells (passages 410-425) were used to study uptake of ]ganciclovir was studied across isolated rabbit cornea. Uptake and transport studies were performed for 2 minutes and 120 minutes, respectively, at 34°C. Thymidine uptake by SIRC displayed saturable kinetics (K m = 595.9 ± 80.4μM, and V max = 289.5 ± 17.2 pmol/min/mg protein). Uptake was inhibited by both purine and pyrimidine nucleosides but not by nucleobases. [ 3 H]thymidine uptake was sodium and energy independent but was inhibited by nitrobenzylthioinosine at nanomolar concentrations. Adenine uptake by SIRC consisted of a saturable component (K m = 14.4 ± 2.3μM, V max = 0.4 ± 0.04 nmol/min/mg protein) and a nonsaturable component. Uptake of adenine was inhibited by purine nucleobases but not by the nucleosides or pyrimidine nucleobases and was independent of sodium, energy, and nitrobenzylthioinosine. 
INTRODUCTION
Corneal epithelial and stromal keratitis, caused by herpes simplex virus type 1 (HSV-1), is the leading cause of blindness in the United States.
1 Antiviral nucleoside analogs such as trifluridine (TFT) and idoxuridine (IDU), and acyclic nucleoside analogs acyclovir (ACV) and ganciclovir (GCV), have been applied topically to treat such infections. [2] [3] [4] However, for topically applied drugs to be effective, the compounds need to penetrate the cornea. The corneal epithelium consists of 5 to 6 layers of columnar epithelial cells that form tight junctions, 5 limiting paracellular diffusion. Since a large number of naturally occurring nucleoside and nucleoside analogs are hydrophilic, 6 transcellular diffusion is also low, thereby limiting the effectiveness of these antiviral agents. In the absence of specialized transport systems, the passage of hydrophilic molecules across the corneal epithelium is thus limited.
In mammalian cells, transcellular flux of nucleosides and nucleobases has been shown to be mediated by specific nucleoside and nucleobase transporters expressed on the cell membranes. 7, 8 These transporters are essential for the cellular salvage of nucleosides and nucleobases for nucleotide and nucleic acid synthesis. Nucleoside transporters are classified into 2 categories based on their sodium dependency: sodium-independent equilibrative nucleoside transporters (facilitated diffusion) and concentrative (sodium dependent) nucleoside transporters. [7] [8] [9] [10] [11] [12] Equilibrative nucleoside transporters are further classified into 2 subtypes on the basis of their sensitivity to nitrobenzylthioinosine (NBT). Equilibrative sensitive type, "es," is inhibited by nanomolar concentrations of NBT (K i 0.1-1nM), whereas the equilibrative insensitive type, "ei," is inhibited by micromolar concentrations of NBT. [7] [8] [9] Both the "es" and the "ei" types of equilibrative transporters exhibit broad substrate specificities for the purine and pyrimidine nucleosides.
Sodium-dependent concentrative systems comprise 5 subtypes, N1 to N5, 7-9,13-16 defined on the basis of substrate selectivity. N1 is selective for the purine nucleosides and uridine, N2 is selective for the pyrimidine nucleosides and adenosine, N3 has broad specificity for both purine and pyrimidine nucleosides, and N4 is pyrimidine selective but also transports adenosine and guanosine but not inosine. The N5 system is NBT sensitive and prefers guanosine as the substrate. 9 Nucleobase transporters, on the other hand, are not so clearly defined. These transporters have been reported to exhibit varying substrate specificities with respect to nucleobases as well as nucleosides. 8, [17] [18] [19] [20] [21] [22] Moreover, both sodium-dependent and sodium-independent nucleobase transporters are expressed on mammalian cells.
So far the cornea remains fairly unexplored with respect to the expression of nucleoside/nucleobase transporters. Recently, we reported for the first time that the rabbit cornea expresses the N3 type sodium-dependent concentrative nucleoside transporter. 23 We also determined that 2 therapeutically effective anti-HSV agents, ACV and IDU, were not substrates for this transporter. These antiviral nucleoside analogs primarily penetrate the cornea by passive diffusion and thus exhibit limited penetration into the deeper layers of the cornea and the aqueous humor. Nucleoside analogs targeted toward the nucleoside transporter expressed on the cornea represent an exciting and clinically relevant strategy to enhance drug concentrations in the deeper corneal layers as well as in the anterior chamber of the eye. However, drug screening for substrates would require use of a large number of corneas. An objective of this research was to investigate whether the Statens Seruminstitut rabbit corneal (SIRC) cell line can serve as an effective in vitro screening tool in identifying nucleoside drugs with affinity for the nucleoside transporter expressed on the cornea. The SIRC cell line was originally derived from the cornea of a normal hare 24 and has been widely used as an in vitro model to assess corneal transport as well as immunological and toxicological responses. [25] [26] [27] [28] [29] [30] [31] However, contradictory reports exist about the epithelial origin of the cell line. Some investigators refer to the cell line as fibroblastic, 24 whereas others claim that it is of epithelial origin. [25] [26] [27] Earlier reports from our laboratory have shown that these cells indeed display epithelial morphology. 31 Several studies reported good correlation between permeability coefficients across SIRC cell line and intact rabbit cornea. 25, 26, 31 Recently, we reported the expression of a large neutral amino acid transporter on the SIRC cell line as well as on the rabbit cornea and the utility of this cell line in screening for prodrugs targeted toward this transporter. 32, 33 These studies, reporting good correlation between uptake by the SIRC cell line and transport across the isolated corneal tissue, suggested that the cell line might serve as a good in vitro model for the rabbit cornea. SIRC is an immortalized cell line and can be propagated several times, as opposed to primary cultures, rendering it more useful as a high-throughput screening tool. Our objective was to determine whether nucleoside/nucleobase transporters are expressed on both the SIRC cell line and the isolated rabbit cornea, with a view toward validating the cell line for further studies. Since our earlier observations indicated that thymidine was transported across the rabbit cornea by a sodiumdependent nucleoside transporter, 23 thymidine was selected as the model nucleoside. GCV was chosen as the model nucleoside drug and adenine as the model nucleobase, since the adenine transporter has been reported to be involved in the transport of GCV. 34, 35 
MATERIALS AND METHODS

Materials
Corneal Transport Studies
MEM containing 10% FBS, lactalbumin, hydroxyl ethyl piperazine ethane sulfonicacid (HEPES), sodium bicarbonate, penicillin (100 μg/mL), and streptomycin (100 μg/mL). The medium was replaced every other day. Cells were maintained at 37°C, in a humidified atmosphere of 5% CO 2 and 90% relative humidity. For uptake studies, cells were plated at a density of 500 000 cells/well on 12-well culture plates and incubated at 37°C.
Permeation of radiolabeled nucleosides ([ 3 H]adenine) and nucleoside analogs ([
3 H]GCV) across isolated rabbit cornea was studied using side-by-side diffusion cells (type-VSC-1, Crown Glass Company Inc, (Somerville, NJ). Corneal membranes isolated from male New Zealand albino rabbit eyes were employed for these studies. Animals were euthanized by an overdose of pentobarbital through the marginal ear vein. Eyes were proptosed, carefully enucleated, and washed with DPBS (pH 7.4) to remove any trace of blood. After a small incision to the sclera, vitreous humor was aspirated using a 1-mL tuberculin syringe. The cornea was carefully excised, leaving some adhered scleral portion. The scleral part attached to the cornea was used to hold the tissue in place between the diffusion half-cells during transport experiments. The lens was removed, and the iris-ciliary body was separated from the cornea using forceps. The cornea was washed immediately with DPBS and mounted on the side-by-side diffusion chambers. The temperature was maintained at 34°C by circulating water through the jacketed chambers of the diffusion apparatus. Both chambers were placed on automated drive consoles that aided in continuous stirring of the donor and receiver cell solutions.
Uptake Studies
Uptake studies were conducted using confluent cultures 10 to 12 days postseeding. The medium was aspirated, and cells were washed 3 times with Dulbecco's phosphate-buffered saline (DPBS) pH 7.4 (130mM NaCl, 7.5mM Na 2 HPO 4 , 1.5mM KH 2 PO 4 , 0.5mM MgSO 4 , 1mM CaCl 2 , 0.03mM KCl, and 5mM glucose) and equilibrated for 1 hour with the buffer. Uptake was carried out for 2 minutes at 34°C (physiological temperature of the rabbit cornea). To determine the sodium dependence of the uptake process, NaCl was replaced with choline chloride, and Na 2 HPO 4 was replaced with K 2 HPO 4 , in equimolar quantities.
Uptake study was initiated by the addition of 2 mL of drug solution (in DPBS) and was terminated after 2 minutes by the addition of ice-cold stop solution (0.52 g/L HEPES and 15.64 g/L KCl). After 3 washings with ice-cold stop solution, cells were lysed overnight, at room temperature, using 1 mL of Triton-X solution (0.1% vol/vol) in 0.3N NaOH. Aliquots (500 μL) from each well were then transferred to scintillation vials containing 5 mL of scintillation cocktail (Fisher Scientific, Fairlawn, NJ). Samples were analyzed with a scintillation counter (Model LS-6500, Beckman Coulter (Fullerton, CA), and rate of uptake was normalized to protein content of each well. Cell lysate protein content was measured by the method of Bradford 36 using bovine serum albumin as the standard (Bio-Rad protein estimation kit, Hercules, CA). Nonspecific binding was corrected by carrying out the uptake at 4°C. Permeant solutions (3 mL) were added on the epithelial side of the cornea (donor chamber). In the receiver chamber, 3.2 mL of DPBS was added. The receiver chamber was kept at a slightly higher volume than the donor chamber such that the hydrostatic pressure difference maintained the natural curvature of the cornea throughout the experiment. The contents in both chambers were stirred continuously using magnetic stir bars. Total duration of the permeation experiment was 2 hours. Donor solution consisted of 0.5 μCi/mL of [ 3 H]adenine or [ 3 H]GCV, in the presence or absence of various nucleosides and nucleoside analogs. Samples of 100 μL were withdrawn from the receiver chamber at selected time points and placed into scintillation vials. Sample volumes were immediately replaced with equal volumes of DPBS. A 5-mL scintillation cocktail was then added to each sample and analyzed in the scintillation counter.
Control experiments using [
14 C]mannitol (0.3 μCi/mL or 1.29 nmol/mL), a paracellular marker, were carried out to evaluate the corneal integrity over the time course of the experiment.
Animals
Adult male New Zealand albino rabbits weighing 2 to 2.5 kgs were obtained from Myrtle's Rabbitry (Thompson station, TN). Experiments involving rabbits conformed to the tenets of the Association for Research in Vision and Ophthalmology statement on animal use in ophthalmic and vision research.
Data Treatment
Uptake data for GCV and adenine were fitted to the modified Michaelis-Menten equation shown in Equation 1:
Studies Using SIRC Cell Line
Concentration-Dependent Uptake of Adenine and Thymidine
Equation 1 takes into account a carrier-mediated process (as described by the classical Michaelis-Menten equation) and a nonsaturable passive diffusion process.
To determine concentration dependency, uptake studies were conducted by spiking 0.5 μCi/mL of [ -5mM) , respectively. Uptake of adenine was found to consist of a saturable component (carrier-mediated process) and a nonsaturable component (Figure 1) . Values for the kinetic constants K m and V max for adenine uptake were calculated to be 14.4 ± 2.3μM and 0.4 ± 0.04 nmol/min/mg protein, respectively. k d had a value of 0.45 ± 0.02 μL/min/mg protein. Saturable and nonsaturable components of adenine uptake process (Figure 1) were determined by substituting the values of the kinetic constants into Equation 1.
V T represents the total rate of uptake, V max is the maximum rate of uptake for the carrier-mediated process, K m denotes the concentration at half-saturation (Michaelis-Menten constant), C represents substrate concentration, and k d is the rate constant for the nonsaturable diffusional component.
Data
, k d × C represents the nonsaturable component, whereas the saturable component of total uptake is represented by (V max × C) /(K m + C). The kinetic parameters, calculated using Kaleida Graph, were substituted into the equation to determine the contribution of the saturable and nonsaturable components. 
Effect of Nucleosides, Nucleobases, and Nucleoside Analogs on Uptake of [ 3 H]Adenine
Uptake studies were carried out with 0.5 μCi (35.7 pmol/mL) of [ 3 H]adenine in the presence and absence of various nucleosides (adenosine, guanosine, and thymidine), nucleobases (unlabeled adenine, guanine, hypoxanthine, thymine, and uracil) and antiviral nucleoside analogs (ACV, GCV, and IDU), as inhibitors of adenine uptake, to examine the substrate specificity of the transporter ( Table 1 ). All inhibitors were at 1mM concentrations. Unlabeled adenine drastically inhibited (98% ± 0.06%) SIRC uptake of [ 3 H]adenine. Substantial inhibition was also achieved with hypoxanthine (66% ± 1.05%) and guanine (34% ± 3.7%). However, the pyrimidine nucleobases thymine and uracil did not affect adenine uptake. Neither the nucleosides nor the nucleoside analogs produced any significant inhibition of [ 3 H]adenine uptake ( Table 1) .
Corneal permeability was determined by normalizing the steady state flux to the donor concentration (C d ) of the drug:
Statistical Analysis
All experiments were conducted at least in triplicate, and results are expressed as mean ± SD. Student t test was used for statistical analysis, and P < .05 was considered to be statistically significant.
Effect of Nucleosides, Nucleobases, and Nucleoside Analogs on Uptake of [ 3 H]Thymidine
Uptake studies were carried out with [ 3 H]thymidine, 0.5 μCi/mL (19.2 pmol/mL), in the presence and absence of various nucleosides, nucleobases, and antiviral nucleoside analogs to examine the substrate specificity of the thymidine transporter. Uptake was significantly decreased in the presence of both purine (adenosine, guanosine, and inosine) and pyrimidine (thymidine and uridine) nucleosides ( Table 2 ). The transport system was most sensitive to thymidine and least sensitive to guanosine. Table 2 also shows the effect of purine (adenine and guanine) and pyrimidine (uracil) nucleobases on the uptake of [ 3 H]thymidine. Uptake was decreased by 31% to 95% of the control in the presence of nucleosides, whereas the nucleobases did not produce any significant inhibition, indicating that the nucleosides are preferred substrates for this transporter.
The acyclic nucleoside analogs ACV and GCV did not exhibit a significant inhibitory effect on [ 3 H]thymidine uptake ( Table 2) . However, nucleoside analogs TFT, IDU, and azidothymidine (AZT) produced a dramatic decrease in [ 3 H]thymidine uptake. (Figure 3) . Inhibitors for Na + / K + -ATPase (ouabain 1mM) and metabolic inhibitors (sodium azide 1mM) were used to further characterize the transport system. Significant differences were not observed in uptake of 
Effect of NBT on [ 3 H]Thymidine and [ 3 H]Adenine Uptake
Sodium-independent nucleoside transport systems are classified into "es" and "ei" types based on their sensitivity to NBT. The "es" type is extremely sensitive to NBT even at nanomolar concentrations ( K i 0.1-10 nM), whereas the "ei" transporter is not inhibited even at 1μM concentrations of NBT. To distinguish between the 2 transporter types on SIRC cells, the nucleoside transporter showing sensitivity to 50nM NBT was classified as the "es" type, and the nucleoside transporter not sensitive to 50nM NBT but sensitive to 250μM NBT was classified as the "ei" type. Stock solutions of NBT were prepared in dimethyl sulfoxide (DMSO). However, the final concentration of DMSO in the uptake medium was less than 2.5%. In these experiments, cells were preincubated with NBT for 15 minutes before initiating uptake. Control studies indicated that 2.5% DMSO did not have any effect on uptake of [ show any statistically significant effect on adenine uptake (data not shown).
Concentration-Dependent Uptake of [ 3 H]GCV
Uptake data of GCV by the SIRC cell line indicated the involvement of 2 processes: a carrier-mediated (saturable) component at low concentrations, and an apparent nonsaturable component at higher concentrations ( Figure 5 ). Studies were conducted by spiking 0.5 μCi/mL of Table 3 shows the uptake of 0.5 μCi/mL (52.6 pmol/mL) [ 3 H]GCV in the absence (control) and presence of various nucleobases (adenine, guanine, thymine, and uracil) or nucleosides (adenosine, guanosine, and thymidine), respectively. While adenine produced significant inhibition (78% ± 1.1%) of [ 3 H]GCV uptake by SIRC cells, the other nucleosides or nucleobases did not produce any substantial inhibition. The calculated value of the passive component of GCV uptake, obtained by substituting the kinetic parameters obtained from Figure 5 into Equation 1, at this concentration is 33.8%. Thus, mathematically, 1mM adenine should have produced 67% inhibition of GCV transport. The experimental and calculated values are therefore close.
Inhibitory Effect of Nucleosides and Nucleobases on Uptake of [ 3 H]GCV
Studies With Intact Rabbit Cornea
Transport of [ 3 H]Adenine Across Isolated Rabbit Cornea
Rate of [
3 H]adenine (0.5 μCi/mL) transport was not affected in the presence of unlabeled adenine, indicating that permeation of adenine across the rabbit cornea probably did not involve any carrier-mediated process (Figure 6 ).
Transport of [ 3 H]Adenine Across Isolated Rabbit Cornea
HPMC gels were prepared at 3% wt/wt while CMC gels were prepared at 1% wt/wt. To potentiate the effect of iontophoresis, terpene enhancers were added to the drug vehicle at a 2% concentration. The cumulative amount of BH permeated across hairless mouse skin using iontophoresis at a current density of 0.1 mA/cm 2 from HPMC and CMC gels was compared to that of the ethanol:water solution. The permeation profile of BH from the gel formulations showed no significant difference from that of the ethanol:water solution (Figure 6) . The BH flux from HPMC was 55.59 ± 11.18 μg/(h.cm 2 ), from the ethanol:water solution was 31.42 ± 7.30 μg/ (h.cm 2 ), and from CMC was 27.19 ± 4.15 μg/(h.cm 2 ).
Terpene enhancers were incorporated to enhance the effect of iontophoresis and to decrease the load of each enhancement technique. Figure 7 and Figure 8 show the effect of terpene enhancers on the flux of BH upon the application of 1 mL gel/cell. Terpene enhancers were superior to iontophoresis. In general, terpene enhancers increased the flux of BH by more than 200-fold relative to a 15-fold increase using iontophoresis alone. However, compared with cineole and terpineol, menthol showed the highest activity. Menthol, cineole, and terpineol increased flux values of BH by 300-, 148-, and 235-fold using HPMC gels and 204-, 140-, and 198-fold using CMC compared to that of the control (HPMC and CMC gels), respectively. However, the use of terpene enhancers in combination with iontophoresis resulted in a synergistic effect on the flux of BH from CMC gel. BH flux increased from 27.19 ± 4.15 and 347.10 ± 14.96 when iontophoresis or menthol were used alone to 546.84 ± 40.54 μg/(h.cm 2 ) when both were combined. This is a synergistic effect. In contrast, the flux of BH from HPMC gels was increased from 55.59 ± 11.18 and 523.10 ± 80.34 using iontophoresis and menthol alone to 637.81 ± 92.88 μg/ (h.cm 2 ) when menthol was combined with iontophoresis. This marginal increase is statistically insignificant and indicates that no synergy occurred under these conditions.
Transport of GCV Across Isolated Rabbit Cornea
Permeability studies were carried out at various concentrations of GCV (0.02, 0.2, and 2.0mM). Solutions were prepared by spiking 0.5 μCi/mL of the radiolabeled species to the unlabeled drug solutions. The amount of radiolabeled species appearing on the donor side was analyzed, and total GCV transported was calculated. Permeability values were determined using Equation 3. As depicted in Figure 7 , permeability values for GCV did not show any statistically significant difference over the concentration range studied.
Moreover, [
3 H]GCV transport across the cornea was not affected in the presence of 1mM adenine (Figure 8 ).
DISCUSSION
Our main objective in this study was to investigate whether the SIRC cell line could be employed as an in vitro tool for screening nucleoside analogs developed for topical administration.
Uptake of thymidine by the SIRC cells exhibited saturable kinetics (Figure 2) , indicating the expression of a nucleoside and/or nucleobase transporter by the SIRC cells. [ 3 H]thymidine uptake was inhibited by both purine and pyrimidine nucleosides but was not affected by the nucleobases ( Table 2) . Moreover, uptake of [ process was independent of sodium ( Figure 3) and was insensitive to NBT. These results indicate that the SIRC cells also express a purine-specific nucleobase transporter, along with an "es" type nucleoside transporter.
However, these observations are in sharp contrast to the observations on the intact cornea with respect to nucleoside/nucleobase transporters. 23 Thymidine transport across the cornea involves a sodium-dependent N3 type nucleoside transporter (K m = 14.9 ± 9.7μM). On the other hand, thymidine uptake by the SIRC cells involves an equilibrative ("es") nucleoside transporter (K m = 595.9 ± 80.4μM). Uptake of adenine by the SIRC cell line appears to be mediated by a purine-specific nucleobase transporter, whereas corneal transport studies suggest that permeation of adenine ( Figure 6 ) and thymine (data not shown) does not involve any nucleobase transport system. The 2 models thus do not seem to correlate with respect to expression of nucleoside/nucleobase carrier systems.
Uptake of GCV by SIRC cells was found to involve a minor saturable component ( Figure 5 ). Inhibition studies with various nucleosides and nucleobases indicated that GCV uptake was significantly inhibited by adenine, and to some extent by guanine, but not by the other nucleosides and nucleobases ( Table 3 ), suggesting that the drug probably shares the adenine transporter. Earlier reports have also shown GCV to be a substrate for nucleobase transporters. 34, 35 Interestingly, GCV did not produce any significant inhibition in the uptake of [ GCV at 1mM would be occupying less than half the available capacity of the nucleoside transporter, while 35 Corneal permeability values of GCV across a 100-fold concentration range remained constant (Figure 7) , suggesting that GCV permeates the corneal tissue by passive diffusion and does not involve any carrier-mediated transport process. Moreover, GCV transport across the cornea was not inhibited by 1mM adenine (Figure 8) . These results thus strengthen our earlier observation that nucleoside/nucleobase transporter expression on the SIRC cell line does not correlate with that on the rabbit cornea.
Cell culture conditions, duration of culture, and degree of differentiation have been reported to influence the level and type of nucleoside/nucleobase transporters expressed.
7,37-39 Del Santo et al 37 reported differential expression of nucleoside transporters in rat liver parenchymal cells and hepatoma cell line. Cell cycle progression and regulation, and degree of differentiation, were shown to be factors responsible for and controlling this differential expression of nucleoside transporters. Pennycooke et al 40 reported that expression patterns of nucleoside transporters vary in normal and tumor tissues. Furthermore, selective loss of nucleoside carrier systems in carcinomas has also been observed. 41 Although SIRC is not a tumor cell line, the process of immortalization of the SIRC cells could have led to changes in the expression pattern. The observed differences in the nucleoside/ nucleobase transporter types expressed on the isolated rabbit cornea and SIRC cell line may thus be evolutionary in nature or could be the result of cell culture conditions. Further studies are necessary to determine whether functional expression of N3-type nucleoside transporters can be induced in the SIRC cell line by changing medium composition, basement matrix, time in culture, and growth factors.
In conclusion, the presence of an "es" type equilibrative nucleoside transporter and a purine-specific nucleobase transporter on the SIRC cell line has been established. However, functional characteristics of these transporters on the SIRC cells differ from those on the isolated rabbit cornea. Transport of nucleosides across the intact rabbit cornea involves a sodium-dependent N3 type nucleoside transporter, whereas carrier-mediated transport is not evident for the purine nucleobases. Such major functional differences between the SIRC cell line and the rabbit cornea with respect to nucleoside/nucleobase transporters, points to the lack of applicability of the SIRC cell line as an in vitro tool for high-throughput screening of nucleoside analogs targeted for topical delivery.
